ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

Outside NIH, Applied Research Underfunded; Strong Federal Role Needed, Chabner Says

May 12, 1995

Funding Opportunities

March 7, 2003

Other Contract Concepts Approved By DCE Board

March 10, 1989

Rose Kushner, Author, Advocate, Dead At 60 Of Breast Cancer

January 19, 1990